Cargando…

[(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism

BACKGROUND: Dopamine transporter (DAT) imaging of striatum is clinically used in Parkinson’s disease (PD) and neurodegenerative parkinsonian syndromes (PS) especially in the early disease stages. The aim of the present study was to evaluate the diagnostic performance of the recently developed tracer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marner, Lisbeth, Korsholm, Kirsten, Anderberg, Lasse, Lonsdale, Markus N., Jensen, Mads Radmer, Brødsgaard, Eva, Denholt, Charlotte L., Gillings, Nic, Law, Ian, Friberg, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452620/ https://www.ncbi.nlm.nih.gov/pubmed/36070114 http://dx.doi.org/10.1186/s13550-022-00930-x

Ejemplares similares

Correction: [(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2023)

Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018)

Imaging of serotonin transporters with [(123)I]FP-CIT SPECT in the human hypothalamus
por: Borgers, Anke J, et al.
Publicado: (2013)

Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
por: Solla, Paolo, et al.
Publicado: (2015)

Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT
por: Matsuda, Hiroshi, et al.
Publicado: (2018)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
por: D’agostino, G., et al.
Publicado: (2023)

Diagnostic value of micrographia in Parkinson’s disease: a study with [(123)I]FP-CIT SPECT
por: Eklund, Mikael, et al.
Publicado: (2022)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis
por: Rahman, Mahmudur G. M., et al.
Publicado: (2018)

A Novel Automatic Approach for Calculation of the Specific Binding Ratio in [I-123]FP-CIT SPECT
por: Rahman, Mahmudur G. M., et al.
Publicado: (2020)

(123)I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies
por: Pardini, Matteo, et al.
Publicado: (2020)

(123)I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component
por: Garriga, Marina, et al.
Publicado: (2015)

Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT
por: Nonokuma, Masanari, et al.
Publicado: (2016)

Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
por: Jeong, Eun Hye, et al.
Publicado: (2018)

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
por: Jeong, Eun Hye, et al.
Publicado: (2022)

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [(123)I]FP-CIT SPECT imaging
por: Dickson, John C., et al.
Publicado: (2017)

Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration
por: Akahoshi, Miho, et al.
Publicado: (2017)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An (123)I-FP-CIT SPECT study
por: van der Zande, J.J., et al.
Publicado: (2019)

β-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia
por: Chen, Qin, et al.
Publicado: (2021)

Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [(123)I]FP-CIT SPECT/CT Brain Imaging
por: Vu, Jeanne P., et al.
Publicado: (2021)

Specific Binding Ratio Estimation of [(123)I]-FP-CIT SPECT Using Frontal Projection Image and Machine Learning
por: Kita, Akinobu, et al.
Publicado: (2023)

Comparison of [(18)F]-FDOPA PET and [(123)I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
por: Wallert, Elon, et al.
Publicado: (2022)

Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients
por: Hida, Kosuke, et al.
Publicado: (2016)

Combination of compressed sensing-based iterative reconstruction and offset acquisition for I-123 FP-CIT SPECT: a simulation study
por: Matsutomo, Norikazu, et al.
Publicado: (2022)

Effect of cerebrospinal fluid area mask correction on (123)I-FP-CIT SPECT images in idiopathic normal pressure hydrocephalus
por: Ohba, Makoto, et al.
Publicado: (2023)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
por: Thomas, Alan J., et al.
Publicado: (2017)

Clinical evaluation of [(123)I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison
por: Adriaanse, Sofie M., et al.
Publicado: (2018)

Validation of Optimum ROI Size for (123)I-FP-CIT SPECT Imaging Using a 3D Mathematical Cylinder Phantom
por: Onishi, Hideo, et al.
Publicado: (2018)

Parkinsonism Associated with Pathological 123I-FP-CIT SPECT (DaTSCAN) Results as the Initial Manifestation of Sporadic Creutzfeldt-Jakob Disease
por: Carrasco García de León, Sira, et al.
Publicado: (2018)

Assessing Nigrostriatal Dopaminergic Pathways via 123I-FP-CIT SPECT in Dementia With Lewy Bodies in a Psychiatric Patient Cohort
por: Hansen, Niels, et al.
Publicado: (2021)

Computer-aided diagnosis for ((123)I)FP-CIT imaging: impact on clinical reporting
por: Taylor, Jonathan Christopher, et al.
Publicado: (2018)

A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [(123)I]I-FP-CIT SPECT in routine practice
por: Chahid, Youssef, et al.
Publicado: (2023)

Fully Automated GMP-Compliant Synthesis of [(18)F]FE-PE2I
por: Bratteby, Klas, et al.
Publicado: (2021)

[(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods
por: Tossici-Bolt, Livia, et al.
Publicado: (2017)

Case Report: Bupropion Reduces the [(123)I]FP-CIT Binding to Striatal Dopamine Transporter
por: Milenkovic, Ivan, et al.
Publicado: (2021)

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
por: Walker, Zuzana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p2ngm50i97lq35943hrn1k85t7